| Reaction Details |
|---|
 | Report a problem with these data |
| Target | MAP kinase-activated protein kinase 2 |
|---|
| Ligand | BDBM50348531 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_754999 (CHEMBL1805901) |
|---|
| IC50 | 60±n/a nM |
|---|
| Citation |  Revesz, L; Schlapbach, A; Aichholz, R; Feifel, R; Hawtin, S; Heng, R; Hiestand, P; Jahnke, W; Koch, G; Kroemer, M; Möbitz, H; Scheufler, C; Velcicky, J; Huppertz, C In vivo and in vitro SAR of tetracyclic MAPKAP-K2 (MK2) inhibitors. Part I. Bioorg Med Chem Lett20:4715-8 (2010) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| MAP kinase-activated protein kinase 2 |
|---|
| Name: | MAP kinase-activated protein kinase 2 |
|---|
| Synonyms: | MAP kinase-activated protein kinase 2 (MAPKAPK2) | MAP kinase-activated protein kinase 2 (MK2) | MAP kinase-activated protein kinase 2 (p38/MK2) | MAPK-Activated Protein Kinase 2 (MK2) | MAPK-activated protein kinase 2 | MAPK2_HUMAN | MAPKAP kinase 2 | MAPKAPK-2 | MAPKAPK2 | MK2 |
|---|
| Type: | Serine/threonine-protein kinase |
|---|
| Mol. Mass.: | 45579.87 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P49137 |
|---|
| Residue: | 400 |
|---|
| Sequence: | MLSNSQGQSPPVPFPAPAPPPQPPTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAII
DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQCPHIVRI
VDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI
NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY
DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM
LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL
ATMRVDYEQIKIKKIEDASNPLLLKRRKKARALEAAALAH
|
|
|
|---|
| BDBM50348531 |
|---|
| n/a |
|---|
| Name | BDBM50348531 |
|---|
| Synonyms: | CHEMBL1801314 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C22H19N3O2 |
|---|
| Mol. Mass. | 357.4052 |
|---|
| SMILES | CNCc1[nH]c2c(ccc3cnc(\C=C\c4ccccc4)cc23)c1C(O)=O |
|---|
| Structure | 
|
|---|
Search and Browse
